Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Small Molecule Anti-tumor Targted Drug Market Growth (Status and Outlook) 2022-2028

  • LP 4801735
  • 100 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Small Molecule Anti-tumor Targted Drug will have significant change from previous year. According to our (LP Information) latest study, the global Small Molecule Anti-tumor Targted Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Small Molecule Anti-tumor Targted Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Small Molecule Anti-tumor Targted Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Small Molecule Anti-tumor Targted Drug market, reaching US$ million by the year 2028. As for the Europe Small Molecule Anti-tumor Targted Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Small Molecule Anti-tumor Targted Drug players cover Astrazeneca, Novartis, Millennium Pharmaceuticals, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Anti-tumor Targted Drug market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

EGFR

ALK

Bcr-Abl

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Liver Cancer

Colorectal Cancer

Lung Cancer

Gastric Cancer

Breast Cancer

Esophageal Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Astrazeneca

Novartis

Millennium Pharmaceuticals

Bayer

Exelixis

Abbvie

Boehringer-Ingelheim

Eisai

Pfizer

Bristol-Myers Squibb

Roche

Bettapharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Small Molecule Anti-tumor Targted Drug Market Size 2017-2028

2.1.2 Small Molecule Anti-tumor Targted Drug Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Small Molecule Anti-tumor Targted Drug Segment by Type

2.2.1 EGFR

2.2.2 ALK

2.2.3 Bcr-Abl

2.2.4 Others

2.3 Small Molecule Anti-tumor Targted Drug Market Size by Type

2.3.1 Small Molecule Anti-tumor Targted Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2022)

2.4 Small Molecule Anti-tumor Targted Drug Segment by Application

2.4.1 Liver Cancer

2.4.2 Colorectal Cancer

2.4.3 Lung Cancer

2.4.4 Gastric Cancer

2.4.5 Breast Cancer

2.4.6 Esophageal Cancer

2.4.7 Others

2.5 Small Molecule Anti-tumor Targted Drug Market Size by Application

2.5.1 Small Molecule Anti-tumor Targted Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2022)

3 Small Molecule Anti-tumor Targted Drug Market Size by Player

3.1 Small Molecule Anti-tumor Targted Drug Market Size Market Share by Players

3.1.1 Global Small Molecule Anti-tumor Targted Drug Revenue by Players (2020-2022)

3.1.2 Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Players (2020-2022)

3.2 Global Small Molecule Anti-tumor Targted Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Small Molecule Anti-tumor Targted Drug by Regions

4.1 Small Molecule Anti-tumor Targted Drug Market Size by Regions (2017-2022)

4.2 Americas Small Molecule Anti-tumor Targted Drug Market Size Growth (2017-2022)

4.3 APAC Small Molecule Anti-tumor Targted Drug Market Size Growth (2017-2022)

4.4 Europe Small Molecule Anti-tumor Targted Drug Market Size Growth (2017-2022)

4.5 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Growth (2017-2022)

5 Americas

5.1 Americas Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022)

5.2 Americas Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022)

5.3 Americas Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Small Molecule Anti-tumor Targted Drug Market Size by Region (2017-2022)

6.2 APAC Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022)

6.3 APAC Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Small Molecule Anti-tumor Targted Drug by Country (2017-2022)

7.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022)

7.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug by Region (2017-2022)

8.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022)

8.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Small Molecule Anti-tumor Targted Drug Market Forecast

10.1 Global Small Molecule Anti-tumor Targted Drug Forecast by Regions (2023-2028)

10.1.1 Global Small Molecule Anti-tumor Targted Drug Forecast by Regions (2023-2028)

10.1.2 Americas Small Molecule Anti-tumor Targted Drug Forecast

10.1.3 APAC Small Molecule Anti-tumor Targted Drug Forecast

10.1.4 Europe Small Molecule Anti-tumor Targted Drug Forecast

10.1.5 Middle East & Africa Small Molecule Anti-tumor Targted Drug Forecast

10.2 Americas Small Molecule Anti-tumor Targted Drug Forecast by Country (2023-2028)

10.2.1 United States Small Molecule Anti-tumor Targted Drug Market Forecast

10.2.2 Canada Small Molecule Anti-tumor Targted Drug Market Forecast

10.2.3 Mexico Small Molecule Anti-tumor Targted Drug Market Forecast

10.2.4 Brazil Small Molecule Anti-tumor Targted Drug Market Forecast

10.3 APAC Small Molecule Anti-tumor Targted Drug Forecast by Region (2023-2028)

10.3.1 China Small Molecule Anti-tumor Targted Drug Market Forecast

10.3.2 Japan Small Molecule Anti-tumor Targted Drug Market Forecast

10.3.3 Korea Small Molecule Anti-tumor Targted Drug Market Forecast

10.3.4 Southeast Asia Small Molecule Anti-tumor Targted Drug Market Forecast

10.3.5 India Small Molecule Anti-tumor Targted Drug Market Forecast

10.3.6 Australia Small Molecule Anti-tumor Targted Drug Market Forecast

10.4 Europe Small Molecule Anti-tumor Targted Drug Forecast by Country (2023-2028)

10.4.1 Germany Small Molecule Anti-tumor Targted Drug Market Forecast

10.4.2 France Small Molecule Anti-tumor Targted Drug Market Forecast

10.4.3 UK Small Molecule Anti-tumor Targted Drug Market Forecast

10.4.4 Italy Small Molecule Anti-tumor Targted Drug Market Forecast

10.4.5 Russia Small Molecule Anti-tumor Targted Drug Market Forecast

10.5 Middle East & Africa Small Molecule Anti-tumor Targted Drug Forecast by Region (2023-2028)

10.5.1 Egypt Small Molecule Anti-tumor Targted Drug Market Forecast

10.5.2 South Africa Small Molecule Anti-tumor Targted Drug Market Forecast

10.5.3 Israel Small Molecule Anti-tumor Targted Drug Market Forecast

10.5.4 Turkey Small Molecule Anti-tumor Targted Drug Market Forecast

10.5.5 GCC Countries Small Molecule Anti-tumor Targted Drug Market Forecast

10.6 Global Small Molecule Anti-tumor Targted Drug Forecast by Type (2023-2028)

10.7 Global Small Molecule Anti-tumor Targted Drug Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Astrazeneca

11.1.1 Astrazeneca Company Information

11.1.2 Astrazeneca Small Molecule Anti-tumor Targted Drug Product Offered

11.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Astrazeneca Main Business Overview

11.1.5 Astrazeneca Latest Developments

11.2 Novartis

11.2.1 Novartis Company Information

11.2.2 Novartis Small Molecule Anti-tumor Targted Drug Product Offered

11.2.3 Novartis Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis Main Business Overview

11.2.5 Novartis Latest Developments

11.3 Millennium Pharmaceuticals

11.3.1 Millennium Pharmaceuticals Company Information

11.3.2 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Offered

11.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Millennium Pharmaceuticals Main Business Overview

11.3.5 Millennium Pharmaceuticals Latest Developments

11.4 Bayer

11.4.1 Bayer Company Information

11.4.2 Bayer Small Molecule Anti-tumor Targted Drug Product Offered

11.4.3 Bayer Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Bayer Main Business Overview

11.4.5 Bayer Latest Developments

11.5 Exelixis

11.5.1 Exelixis Company Information

11.5.2 Exelixis Small Molecule Anti-tumor Targted Drug Product Offered

11.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Exelixis Main Business Overview

11.5.5 Exelixis Latest Developments

11.6 Abbvie

11.6.1 Abbvie Company Information

11.6.2 Abbvie Small Molecule Anti-tumor Targted Drug Product Offered

11.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Abbvie Main Business Overview

11.6.5 Abbvie Latest Developments

11.7 Boehringer-Ingelheim

11.7.1 Boehringer-Ingelheim Company Information

11.7.2 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Offered

11.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Boehringer-Ingelheim Main Business Overview

11.7.5 Boehringer-Ingelheim Latest Developments

11.8 Eisai

11.8.1 Eisai Company Information

11.8.2 Eisai Small Molecule Anti-tumor Targted Drug Product Offered

11.8.3 Eisai Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Eisai Main Business Overview

11.8.5 Eisai Latest Developments

11.9 Pfizer

11.9.1 Pfizer Company Information

11.9.2 Pfizer Small Molecule Anti-tumor Targted Drug Product Offered

11.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Pfizer Main Business Overview

11.9.5 Pfizer Latest Developments

11.10 Bristol-Myers Squibb

11.10.1 Bristol-Myers Squibb Company Information

11.10.2 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Offered

11.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Bristol-Myers Squibb Main Business Overview

11.10.5 Bristol-Myers Squibb Latest Developments

11.11 Roche

11.11.1 Roche Company Information

11.11.2 Roche Small Molecule Anti-tumor Targted Drug Product Offered

11.11.3 Roche Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Roche Main Business Overview

11.11.5 Roche Latest Developments

11.12 Bettapharma

11.12.1 Bettapharma Company Information

11.12.2 Bettapharma Small Molecule Anti-tumor Targted Drug Product Offered

11.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Bettapharma Main Business Overview

11.12.5 Bettapharma Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Small Molecule Anti-tumor Targted Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of EGFR

Table 3. Major Players of ALK

Table 4. Major Players of Bcr-Abl

Table 5. Major Players of Others

Table 6. Small Molecule Anti-tumor Targted Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2022)

Table 9. Small Molecule Anti-tumor Targted Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2022)

Table 12. Global Small Molecule Anti-tumor Targted Drug Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Player (2020-2022)

Table 14. Small Molecule Anti-tumor Targted Drug Key Players Head office and Products Offered

Table 15. Small Molecule Anti-tumor Targted Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Small Molecule Anti-tumor Targted Drug Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Regions (2017-2022)

Table 20. Americas Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Country (2017-2022)

Table 22. Americas Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2022)

Table 24. Americas Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2022)

Table 26. APAC Small Molecule Anti-tumor Targted Drug Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Region (2017-2022)

Table 28. APAC Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2022)

Table 30. APAC Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2022)

Table 32. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Country (2017-2022)

Table 34. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2022)

Table 36. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Small Molecule Anti-tumor Targted Drug

Table 45. Key Market Challenges & Risks of Small Molecule Anti-tumor Targted Drug

Table 46. Key Industry Trends of Small Molecule Anti-tumor Targted Drug

Table 47. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share Forecast by Application (2023-2028)

Table 53. Astrazeneca Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 54. Astrazeneca Small Molecule Anti-tumor Targted Drug Product Offered

Table 55. Astrazeneca Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Astrazeneca Main Business

Table 57. Astrazeneca Latest Developments

Table 58. Novartis Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 59. Novartis Small Molecule Anti-tumor Targted Drug Product Offered

Table 60. Novartis Main Business

Table 61. Novartis Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Novartis Latest Developments

Table 63. Millennium Pharmaceuticals Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 64. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Offered

Table 65. Millennium Pharmaceuticals Main Business

Table 66. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Millennium Pharmaceuticals Latest Developments

Table 68. Bayer Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 69. Bayer Small Molecule Anti-tumor Targted Drug Product Offered

Table 70. Bayer Main Business

Table 71. Bayer Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Bayer Latest Developments

Table 73. Exelixis Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 74. Exelixis Small Molecule Anti-tumor Targted Drug Product Offered

Table 75. Exelixis Main Business

Table 76. Exelixis Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Exelixis Latest Developments

Table 78. Abbvie Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 79. Abbvie Small Molecule Anti-tumor Targted Drug Product Offered

Table 80. Abbvie Main Business

Table 81. Abbvie Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Abbvie Latest Developments

Table 83. Boehringer-Ingelheim Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 84. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Offered

Table 85. Boehringer-Ingelheim Main Business

Table 86. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Boehringer-Ingelheim Latest Developments

Table 88. Eisai Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 89. Eisai Small Molecule Anti-tumor Targted Drug Product Offered

Table 90. Eisai Main Business

Table 91. Eisai Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Eisai Latest Developments

Table 93. Pfizer Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 94. Pfizer Small Molecule Anti-tumor Targted Drug Product Offered

Table 95. Pfizer Main Business

Table 96. Pfizer Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Pfizer Latest Developments

Table 98. Bristol-Myers Squibb Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 99. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Offered

Table 100. Bristol-Myers Squibb Main Business

Table 101. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Bristol-Myers Squibb Latest Developments

Table 103. Roche Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 104. Roche Small Molecule Anti-tumor Targted Drug Product Offered

Table 105. Roche Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Roche Main Business

Table 107. Roche Latest Developments

Table 108. Bettapharma Details, Company Type, Small Molecule Anti-tumor Targted Drug Area Served and Its Competitors

Table 109. Bettapharma Small Molecule Anti-tumor Targted Drug Product Offered

Table 110. Bettapharma Main Business

Table 111. Bettapharma Small Molecule Anti-tumor Targted Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Bettapharma Latest Developments

List of Figures

Figure 1. Small Molecule Anti-tumor Targted Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2021

Figure 7. Small Molecule Anti-tumor Targted Drug in Liver Cancer

Figure 8. Global Small Molecule Anti-tumor Targted Drug Market: Liver Cancer (2017-2022) & ($ Millions)

Figure 9. Small Molecule Anti-tumor Targted Drug in Colorectal Cancer

Figure 10. Global Small Molecule Anti-tumor Targted Drug Market: Colorectal Cancer (2017-2022) & ($ Millions)

Figure 11. Small Molecule Anti-tumor Targted Drug in Lung Cancer

Figure 12. Global Small Molecule Anti-tumor Targted Drug Market: Lung Cancer (2017-2022) & ($ Millions)

Figure 13. Small Molecule Anti-tumor Targted Drug in Gastric Cancer

Figure 14. Global Small Molecule Anti-tumor Targted Drug Market: Gastric Cancer (2017-2022) & ($ Millions)

Figure 15. Small Molecule Anti-tumor Targted Drug in Breast Cancer

Figure 16. Global Small Molecule Anti-tumor Targted Drug Market: Breast Cancer (2017-2022) & ($ Millions)

Figure 17. Small Molecule Anti-tumor Targted Drug in Esophageal Cancer

Figure 18. Global Small Molecule Anti-tumor Targted Drug Market: Esophageal Cancer (2017-2022) & ($ Millions)

Figure 19. Small Molecule Anti-tumor Targted Drug in Others

Figure 20. Global Small Molecule Anti-tumor Targted Drug Market: Others (2017-2022) & ($ Millions)

Figure 21. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2021

Figure 22. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Player in 2021

Figure 23. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Regions (2017-2022)

Figure 24. Americas Small Molecule Anti-tumor Targted Drug Market Size 2017-2022 ($ Millions)

Figure 25. APAC Small Molecule Anti-tumor Targted Drug Market Size 2017-2022 ($ Millions)

Figure 26. Europe Small Molecule Anti-tumor Targted Drug Market Size 2017-2022 ($ Millions)

Figure 27. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size 2017-2022 ($ Millions)

Figure 28. Americas Small Molecule Anti-tumor Targted Drug Value Market Share by Country in 2021

Figure 29. Americas Small Molecule Anti-tumor Targted Drug Consumption Market Share by Type in 2021

Figure 30. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2021

Figure 31. United States Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 32. Canada Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 33. Mexico Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 34. Brazil Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 35. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Region in 2021

Figure 36. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2021

Figure 37. China Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 38. Japan Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 39. Korea Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 40. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 41. India Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 42. Australia Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 43. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Country in 2021

Figure 44. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2021

Figure 45. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2021

Figure 46. Germany Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 47. France Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 48. UK Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 49. Italy Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 50. Russia Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 51. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Region in 2021

Figure 52. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2021

Figure 53. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2021

Figure 54. Egypt Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 55. South Africa Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 56. Israel Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 57. Turkey Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 58. GCC Country Small Molecule Anti-tumor Targted Drug Market Size Growth 2017-2022 ($ Millions)

Figure 59. Americas Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 60. APAC Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 61. Europe Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 62. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 63. United States Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 64. Canada Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 65. Mexico Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 66. Brazil Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 67. China Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 68. Japan Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 69. Korea Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 70. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 71. India Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 72. Australia Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 73. Germany Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 74. France Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 75. UK Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 76. Italy Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 77. Russia Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 78. Spain Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 79. Egypt Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 80. South Africa Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 81. Israel Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 82. Turkey Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

Figure 83. GCC Countries Small Molecule Anti-tumor Targted Drug Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390